Standardized Hawthorn Extract — Bulk Supply for Cardiovascular Nutraceuticals

Cardiovascular formulators need a hawthorn input they can build a label claim around — and that means standardisation. Crataegus monogyna and Crataegus laevigata leaf-and-flower or berry extracts dosed in finished nutraceuticals are typically supplied as DER 4:1 or 5:1, standardised to 1.8-2.5% total flavonoids expressed as hyperoside, with vitexin and rutin reported on the spec sheet.

TANDOR brokers hawthorn raw material and contract-extracted concentrates from Romanian and wider Carpathian botanical collectors who have worked with the European herbal trade for decades. Wild-harvested berry and leaf-flower lots are dried under controlled conditions to protect the flavonoid fraction, then routed either as cut-and-sifted herb for in-house extraction or as a finished hydroalcoholic extract powder on a maltodextrin or acacia gum carrier. Each lot carries HPLC quantification of the marker compounds, residual solvent results within ICH Q3C limits where applicable, microbiological screening, heavy-metals data referenced to EU 2023/915, and pesticide-residue analysis. EU-Organic certification is available on request with the control-body code on the Certificate of Analysis.

Packaging is 20 or 25 kg fibre drums with food-grade liners; bulk herb lots ship in 15-20 kg multi-wall paper sacks. Standard lead time on inventory grades is 14-21 days, with extended timing for organic-certified or higher-flavonoid specifications. We coordinate DDP delivery into EU pharmaceutical and supplement manufacturers, and we are set up to handle the documentation flow your QA team expects — TDS, CoA, allergen statement, GMO-free declaration, country-of-origin certificate. Send us your flavonoid target, DER and packaging preference and we will return a firm offer within 24 hours.